ID   EPHA8_HUMAN             Reviewed;        1005 AA.
AC   P29322; Q9NUA9; Q9P269;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   02-NOV-2010, entry version 121.
DE   RecName: Full=Ephrin type-A receptor 8;
DE            EC=2.7.10.1;
DE   AltName: Full=EPH- and ELK-related kinase;
DE   AltName: Full=EPH-like kinase 3;
DE            Short=EK3;
DE            Short=hEK3;
DE   AltName: Full=Tyrosine-protein kinase receptor EEK;
DE   Flags: Precursor;
GN   Name=EPHA8; Synonyms=EEK, KIAA1459;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 153-1005, AND VARIANT
RP   GLN-612.
RC   TISSUE=Brain;
RX   MEDLINE=20277482; PubMed=10819331; DOI=10.1093/dnares/7.2.143;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVII.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:143-150(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 706-726.
RX   MEDLINE=91296384; PubMed=1648701;
RA   Chan J., Watt V.M.;
RT   "eek and erk, new members of the eph subclass of receptor protein-
RT   tyrosine kinases.";
RL   Oncogene 6:1057-1061(1991).
RN   [4]
RP   INTERACTION WITH ANKS1B.
RX   PubMed=17875921; DOI=10.1128/MCB.00794-07;
RA   Shin J., Gu C., Park E., Park S.;
RT   "Identification of phosphotyrosine binding domain-containing proteins
RT   as novel downstream targets of the EphA8 signaling function.";
RL   Mol. Cell. Biol. 27:8113-8126(2007).
RN   [5]
RP   STRUCTURE BY NMR OF 437-534 AND 932-1000.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second FN3 domain and of sterile alpha
RT   motif (SAM) domain of EPH receptor A8 protein.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-45; LEU-60; LYS-123; CYS-179;
RP   LEU-198 AND LEU-860.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with FYN (By similarity). Interacts with
CC       ANKS1B.
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- PTM: Phosphorylation on Tyr-616 is critical for association with
CC       FYN (By similarity).
CC   -!- PTM: Phosphorylation on Tyr-839 modulates tyrosine kinase activity
CC       (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily.
CC   -!- SIMILARITY: Contains 2 fibronectin type-III domains.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SIMILARITY: Contains 1 SAM (sterile alpha motif) domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA41980.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL035703; CAB81612.1; -; Genomic_DNA.
DR   EMBL; AB040892; BAA95983.1; -; mRNA.
DR   EMBL; X59291; CAA41980.1; ALT_INIT; Genomic_DNA.
DR   IPI; IPI00021274; -.
DR   PIR; S23361; S23361.
DR   RefSeq; NP_065387.1; -.
DR   UniGene; Hs.283613; -.
DR   PDB; 1UCV; NMR; -; A=933-1000.
DR   PDB; 1X5L; NMR; -; A=437-534.
DR   PDB; 3KUL; X-ray; 2.15 A; A/B=602-909.
DR   PDBsum; 1UCV; -.
DR   PDBsum; 1X5L; -.
DR   PDBsum; 3KUL; -.
DR   ProteinModelPortal; P29322; -.
DR   SMR; P29322; 30-203, 326-534, 622-899.
DR   STRING; P29322; -.
DR   PhosphoSite; P29322; -.
DR   PRIDE; P29322; -.
DR   Ensembl; ENST00000166244; ENSP00000166244; ENSG00000070886.
DR   GeneID; 2046; -.
DR   UCSC; uc001bfx.1; human.
DR   CTD; 2046; -.
DR   GeneCards; GC01P022890; -.
DR   HGNC; HGNC:3391; EPHA8.
DR   HPA; CAB009660; -.
DR   HPA; HPA031433; -.
DR   MIM; 176945; gene.
DR   PharmGKB; PA27823; -.
DR   eggNOG; prNOG19553; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; P29322; -.
DR   OMA; VTTRATV; -.
DR   OrthoDB; EOG90GG94; -.
DR   PhylomeDB; P29322; -.
DR   BRENDA; 2.7.10.1; 247.
DR   Pathway_Interaction_DB; epha_fwdpathway; EPHA forward signaling.
DR   Pathway_Interaction_DB; ephrina_ephapathway; EphrinA-EPHA pathway.
DR   NextBio; 8315; -.
DR   ArrayExpress; P29322; -.
DR   Bgee; P29322; -.
DR   CleanEx; HS_EPHA8; -.
DR   Genevestigator; P29322; -.
DR   GermOnline; ENSG00000070886; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005515; F:protein binding; IEA:InterPro.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; TAS:ProtInc.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kin...; IEA:InterPro.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd.
DR   InterPro; IPR008957; Fibronectin_III_dom.
DR   InterPro; IPR003961; FN_III.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM_type.
DR   InterPro; IPR021129; SAM_type1.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR010993; Sterile_alpha_motif_homology.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   InterPro; IPR020768; Tyr_prot_kinase_EphA_rcpt.
DR   InterPro; IPR016257; Tyr_prot_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_prot_kinase_rcpt_V_CS.
DR   Gene3D; G3DSA:2.60.40.10; Ig-like_fold; 2.
DR   Gene3D; G3DSA:1.10.150.50; SAM_type; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   PANTHER; PTHR23256:SF278; Tyr_prot_kinase_EphA_rcpt; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF49265; FN_III-like; 2.
DR   SUPFAM; SSF49785; Gal_bind_like; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   SUPFAM; SSF47769; SAM_homology; 1.
DR   PROSITE; PS01186; EGF_2; UNKNOWN_1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycoprotein; Kinase;
KW   Membrane; Nucleotide-binding; Phosphoprotein; Polymorphism; Receptor;
KW   Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase.
FT   SIGNAL        1     30       Potential.
FT   CHAIN        31   1005       Ephrin type-A receptor 8.
FT                                /FTId=PRO_0000016822.
FT   TOPO_DOM     31    542       Extracellular (Potential).
FT   TRANSMEM    543    563       Helical; (Potential).
FT   TOPO_DOM    564   1005       Cytoplasmic (Potential).
FT   DOMAIN      328    430       Fibronectin type-III 1.
FT   DOMAIN      436    531       Fibronectin type-III 2.
FT   DOMAIN      635    896       Protein kinase.
FT   DOMAIN      930    994       SAM.
FT   NP_BIND     641    649       ATP (By similarity).
FT   MOTIF      1003   1005       PDZ-binding (Potential).
FT   COMPBIAS    191    325       Cys-rich.
FT   ACT_SITE    760    760       Proton acceptor (By similarity).
FT   BINDING     667    667       ATP (By similarity).
FT   MOD_RES     616    616       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   MOD_RES     839    839       Phosphotyrosine; by autocatalysis (By
FT                                similarity).
FT   CARBOHYD    340    340       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    407    407       N-linked (GlcNAc...) (Potential).
FT   CARBOHYD    432    432       N-linked (GlcNAc...) (Potential).
FT   VARIANT      45     45       G -> S (in dbSNP:rs45498698).
FT                                /FTId=VAR_042153.
FT   VARIANT      60     60       V -> L (in dbSNP:rs56402644).
FT                                /FTId=VAR_042154.
FT   VARIANT     123    123       N -> K (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042155.
FT   VARIANT     179    179       R -> C (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042156.
FT   VARIANT     198    198       R -> L (in a lung adenocarcinoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042157.
FT   VARIANT     321    321       P -> L (in dbSNP:rs56656925).
FT                                /FTId=VAR_061292.
FT   VARIANT     444    444       V -> M (in dbSNP:rs2295021).
FT                                /FTId=VAR_022107.
FT   VARIANT     612    612       E -> Q (in dbSNP:rs999765).
FT                                /FTId=VAR_024514.
FT   VARIANT     860    860       P -> L (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_042158.
FT   CONFLICT    237    237       S -> L (in Ref. 2; BAA95983).
FT   STRAND      456    460
FT   STRAND      472    482
FT   STRAND      488    499
FT   STRAND      507    510
FT   STRAND      512    516
FT   STRAND      527    530
FT   HELIX       935    941
FT   HELIX       945    947
FT   HELIX       948    953
FT   HELIX       959    962
FT   HELIX       967    973
FT   HELIX       978    995
SQ   SEQUENCE   1005 AA;  111003 MW;  6FBF85535E4212B3 CRC64;
     MAPARGRLPP ALWVVTAAAA AATCVSAARG EVNLLDTSTI HGDWGWLTYP AHGWDSINEV
     DESFQPIHTY QVCNVMSPNQ NNWLRTSWVP RDGARRVYAE IKFTLRDCNS MPGVLGTCKE
     TFNLYYLESD RDLGASTQES QFLKIDTIAA DESFTGADLG VRRLKLNTEV RSVGPLSKRG
     FYLAFQDIGA CLAILSLRIY YKKCPAMVRN LAAFSEAVTG ADSSSLVEVR GQCVRHSEER
     DTPKMYCSAE GEWLVPIGKC VCSAGYEERR DACVACELGF YKSAPGDQLC ARCPPHSHSA
     APAAQACHCD LSYYRAALDP PSSACTRPPS APVNLISSVN GTSVTLEWAP PLDPGGRSDI
     TYNAVCRRCP WALSRCEACG SGTRFVPQQT SLVQASLLVA NLLAHMNYSF WIEAVNGVSD
     LSPEPRRAAV VNITTNQAAP SQVVVIRQER AGQTSVSLLW QEPEQPNGII LEYEIKYYEK
     DKEMQSYSTL KAVTTRATVS GLKPGTRYVF QVRARTSAGC GRFSQAMEVE TGKPRPRYDT
     RTIVWICLTL ITGLVVLLLL LICKKRHCGY SKAFQDSDEE KMHYQNGQAP PPVFLPLHHP
     PGKLPEPQFY AEPHTYEEPG RAGRSFTREI EASRIHIEKI IGSGDSGEVC YGRLRVPGQR
     DVPVAIKALK AGYTERQRRD FLSEASIMGQ FDHPNIIRLE GVVTRGRLAM IVTEYMENGS
     LDTFLRTHDG QFTIMQLVGM LRGVGAGMRY LSDLGYVHRD LAARNVLVDS NLVCKVSDFG
     LSRVLEDDPD AAYTTTGGKI PIRWTAPEAI AFRTFSSASD VWSFGVVMWE VLAYGERPYW
     NMTNRDVISS VEEGYRLPAP MGCPHALHQL MLDCWHKDRA QRPRFSQIVS VLDALIRSPE
     SLRATATVSR CPPPAFVRSC FDLRGGSGGG GGLTVGDWLD SIRMGRYRDH FAAGGYSSLG
     MVLRMNAQDV RALGITLMGH QKKILGSIQT MRAQLTSTQG PRRHL
//
